CDX2 and colorectal carcinoma: To verify whether Ascl2 can repress CDX2 gene expression in human colorectal cancer, quantitative real-time PCR was used to measure Ascl2, CDX2, and MUC2 mRNA levels in 50 CRC samples and their corresponding pericancerous mucosa.